Mitchell S. V. Elkind, M.D., M.S., FAHA
Immediate Past President
Dr. Mitchell Elkind is immediate past president of the American Heart Association for 2021-22, a tenured Professor of Neurology and Epidemiology at Columbia University, and Chief of the Division of Neurology Clinical Outcomes Research and Population Sciences in the Neurology Department.
Dr Elkind’s research focuses on stroke prevention, inflammatory and infectious biomarkers in stroke risk prediction, atrial cardiopathy, immune therapy for acute stroke, and vascular causes of cognitive aging. He is a principal investigator of federally-funded studies examining atrial cardiopathy in cryptogenic stroke; stroke risk factors; short-term high-dose statin therapy in acute stroke; and inflammation in stroke treatment.
Dr. Elkind has a longstanding commitment to medical education and research training. In addition to leading the Columbia Neurology residency and fellowship programs, he serves as editor of the AHA/ASA Stroke journal’s new International Stroke Early Career and Training Section. He also runs National Institutes of Health-funded research training programs for residents and fellows.
As a long-time AHA volunteer, Dr. Elkind has served on numerous leadership committees, including three terms on the National Board of Directors, two terms as chairperson of the ASA Advisory Committee (2016-20), and is a past chairperson of the Science Advisory and Coordinating Committee (2020-21), and co-chair or member of several writing committees for guidelines and scientific statements. He co-chaired the writing committee for the 2012 scientific statement on the inclusion of stroke as an outcome and risk equivalent in vascular disease risk scores.
For 2021-22, Dr. Elkind will serve as co-chair of the Association’s Governance Committee, as well as chairperson of the Manuscript Oversight Committee and Awards Subcommittee. He is a current member of National Board of Directors, Executive Committee, Advocacy Coordinating Committee, Compensation, Benefits & HR Committee, Corporate Operations Coordinating Committee, International Committee, Research Committee and Research Funding Subcommittee. He also serves on the AHA’s Eastern States Region Board of Directors and New York City Board.
In 2021, Dr. Elkind was honored with the AHA’s Distinguished National Leadership Award.